Patents by Inventor Hans-Erik Claesson

Hans-Erik Claesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for identifying modulators of eoxin formation
    Publication number: 20090247634
    Abstract: A method for identifying a compound for modulating the formation of 14,15-LTC4 (Eoxin C4; EoxC4), 14,15-LTD4 (Eoxin D4; EoxD4), or 14,15-LTE4 (Eoxin E4; EoxE4) in a biological system. A method for identifying a compound with an anti-inflammatory effect, the method comprising testing the compound for an effect on formation and/or activity of 14,15-LTC4 (Eoxin C4; EoxC4), 14,15-LTD4 (Eoxin D4; EoxD4), or 14,15-LTE4 (Eoxin E4; EoxE4) in a biological system. A method of making an anti-inflammatory composition or Eoxin formation-modulating composition comprising (i) identifying an anti-inflammatory compound or Eoxin formation-modulating compound by a method of the invention; (ii) combining the compound with a pharmaceutically acceptable excipient or carrier.
    Type: Application
    Filed: June 27, 2007
    Publication date: October 1, 2009
    Inventors: Hans-Erik Claesson, Magnus Bjorkholm
  • Use of Ltb4 Inhibitors for the Treatment of B-Cell Leukemias and Lymphomas
    Publication number: 20080081835
    Abstract: The invention relates to the use of an inhibitor of the biosynthesis and/or function of LTB4 for the manufacture of a medicament for the treatment of B-cell chronic lymphocytic leukemia (B-CLL), B-prolymphocytic leukemia (B-PLL) or B-cell lymphoma. Preferably, the inhibitor of the biosynthesis and/or function of LTB4 is the inhibitor of 5-LO BWA4C or the inhibitor of FLAP MK-886.
    Type: Application
    Filed: May 5, 2005
    Publication date: April 3, 2008
    Inventors: Hans-Erik Claesson, Magnus Bjorkholm